Unleashing Immunity against Cancer: Nobel Prize in Physiology or Medicine

James P. Allison and and Tasuku Honjo shared the Nobel Prize for their discovery of inhibition of negative immune regulation, the basis of new drugs against cancer.

Join Our Community of Science Lovers!

[Allison talking on the phone.]

James P. Allison, who was awarded a Nobel Prize today, along with Tasuku Honjo. Allison was talking to a Nobel Assembly representative on the phone. This is Scientific American’s Science Talk, I’m Steve Mirsky, on October 1st 2018. Thomas Perlmann, Secretary of the Nobel Assembly, made the announcement:

“The Nobel Assembly at Karolinska Institute has today decided to award the 2018 Nobel Prize in Physiology or Medicine, jointly to James P. Allison and and Tasuku Honjo for their discovery ofcancer therapy by inhibition of negative immune regulation.


On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.


“James P. Allison was born in Alice, in Texas, in the United States. He performed his prize-winning studies at the University of California, Berkeley, and at Memorial Sloan Kettering Cancer Center in New York. He is now active at The University of Texas M. D. Anderson Cancer Center in Houston. Tasuku Honjo was born in Kyoto, in Japan. He performed his prize-winning studies at Kyoto University, where he is still active.”

Karolinska Institute immunologist Klas Kärre, a member of the Nobel Committee, then gave a more in-depth explanation of the research behind this year’s prize.

Kärre Segment

Following a brief press conference, Kärre spoke to an unnamed interviewer.  

Kärre Interview

We’ll be back tomorrow with coverage of the Nobel Prize in Physics. We leave you with new Nobel laureate James Allison’s harmonica stylings, as he played with the band the Checkmates, at the 2017 meeting of the Society for Immunotherapy of Cancer. The vocalist is Rachel Humphrey, MD.   

It’s Time to Stand Up for Science

If you enjoyed this article, I’d like to ask for your support. Scientific American has served as an advocate for science and industry for 180 years, and right now may be the most critical moment in that two-century history.

I’ve been a Scientific American subscriber since I was 12 years old, and it helped shape the way I look at the world. SciAm always educates and delights me, and inspires a sense of awe for our vast, beautiful universe. I hope it does that for you, too.

If you subscribe to Scientific American, you help ensure that our coverage is centered on meaningful research and discovery; that we have the resources to report on the decisions that threaten labs across the U.S.; and that we support both budding and working scientists at a time when the value of science itself too often goes unrecognized.

In return, you get essential news, captivating podcasts, brilliant infographics, can't-miss newsletters, must-watch videos, challenging games, and the science world's best writing and reporting. You can even gift someone a subscription.

There has never been a more important time for us to stand up and show why science matters. I hope you’ll support us in that mission.

Thank you,

David M. Ewalt, Editor in Chief, Scientific American

Subscribe